PF-07976016 / Pfizer - LARVOL DELTA

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men (clinicaltrials.gov) - P1 | N=8 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity (clinicaltrials.gov) - P2 | N=232 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting

Enrollment closed • Genetic Disorders • Obesity

Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity (clinicaltrials.gov) - P1 | N=21 | Terminated | Sponsor: Pfizer | Active, not recruiting ➔ Terminated; The sponsor has made the decision to discontinue development of danuglipron (PF-06882961). As such, this study was discontinued prior to PF-06882961 administration.

Trial termination • Genetic Disorders • Obesity

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men (clinicaltrials.gov) - P1 | N=8 | Not yet recruiting | Sponsor: Pfizer

New P1 trial

Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity (clinicaltrials.gov) - P1 | N=21 | Active, not recruiting | Sponsor: Pfizer | N=32 ➔ 21 | Recruiting ➔ Active, not recruiting

Enrollment change • Enrollment closed • Genetic Disorders • Obesity

Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Pfizer

New P1 trial • Genetic Disorders • Obesity

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults (clinicaltrials.gov) - P1 | N=12 | Completed | Sponsor: Pfizer | Recruiting ➔ Completed

Trial completion

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity (clinicaltrials.gov) - P2 | N=252 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open • Genetic Disorders • Obesity

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity (clinicaltrials.gov) - P2 | N=252 | Not yet recruiting | Sponsor: Pfizer

New P2 trial • Genetic Disorders • Obesity

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Pfizer

New P1 trial

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults (clinicaltrials.gov) - P1 | N=117 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed

Trial completion

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults (clinicaltrials.gov) - P1 | N=110 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults (clinicaltrials.gov) - P1 | N=146 | Recruiting | Sponsor: Pfizer | Trial completion date: Mar 2024 ➔ Sep 2024 | Trial primary completion date: Mar 2024 ➔ Sep 2024

Trial completion date • Trial primary completion date